Moderna Inc said on Wednesday it will ask regulators to authorize its COVID-19 vaccine in children younger than 6 years old based on data showing it generated a similar immune response to adults in its clinical trial
Moderna Inc said on Wednesday (March 23) it will ask regulators to authorise its Covid-19 vaccine in children younger than six years old based on data showing it generated a similar immune response to adults in its clinical trial. The Omicron variant of Covid-19 was predominant during Moderna's pediatric trial, and the drugmaker said two doses were around 38 per.
Moderna Inc (MRNA.O) said on Wednesday it will ask regulators to authorize its COVID-19 vaccine in children younger than 6 years old based on data showing it generated a similar immune response to adults in its clinical trial.
Moderna COVID-19 vaccine poised for US greenlight after FDA advisory panel endorsement abc11.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abc11.com Daily Mail and Mail on Sunday newspapers.